Nexium (Esomeprazole)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as an injection solution for intravenous use. It reduces gastric acid secretion and is employed in the treatment of gastroesophageal reflux disease, erosive esophagitis, peptic ulcer disease, and prevention of NSAID‑induced gastric ulcers in adult patients.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory support for institutional buyers. Our distribution network ensures consistent product quality and compliance with EU standards.

Esomeprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders. - Gastroesophageal reflux disease (GERD): Reduces acid exposure to relieve symptoms and promote healing of the esophagus. - Erosive esophagitis: Facilitates mucosal repair by maintaining a higher gastric pH. - Peptic ulcer disease: Supports ulcer healing and prevents recurrence by suppressing gastric acid. - Prevention of NSAID‑induced gastric ulcers: Provides prophylactic acid suppression in patients receiving non‑steroidal anti‑inflammatory drugs.

Common Side Effects: - Headache: mild to moderate pain often reported. - Diarrhea: loose stools occurring during treatment. - Nausea: feeling of queasiness or upset stomach. - Abdominal pain: discomfort in the stomach region. - Flatulence: increased intestinal gas. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: severe diarrhea with abdominal pain. - Low magnesium levels: muscle cramps, irregular heartbeat. - Liver enzyme elevation: abnormal liver function tests. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash. - Bone fractures: increased risk with long‑term use.

Before initiating therapy, consider the following precautions: - Assess renal function: dose adjustment may be needed in severe impairment. - Evaluate hepatic status: use with caution in patients with liver disease. - Monitor electrolytes: especially magnesium during prolonged treatment. - Review concomitant medications: potential for drug‑drug interactions. - Pregnancy and lactation: safety not established; weigh benefits against risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Esomeprazole may affect the pharmacokinetics of several co‑administered drugs. Major Interactions (Avoid): - Ketoconazole: reduced absorption leading to therapeutic failure. - Atazanavir: markedly decreased plasma concentrations. - Warfarin: potential increase in anticoagulant effect. Moderate Interactions (Monitor Closely): - Clopidogrel: diminished antiplatelet activity. - Digoxin: possible increase in serum levels. - Methotrexate: enhanced toxicity at high doses.